AD

(4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside(CAS: 27994-11-2)

(4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi
cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside
CAS Number

Related Products

Other Suppliers for (4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside

Basic Information

Molecular Formula
C35H52O9
Molecular Weight
616.79 g/mol
Physical State
Powder

Chemical Identifiers

SMILES
CC1CC2C(OC3(C1C4(CCC56CC57CCC(C(C7CCC6C4(C3O)C)(C)C)OC8C(C(C(CO8)O)O)O)C)O2)C(C)(C)O
InChIKey
GQLUAQZLAZUHEL-NKMZKCBCSA-N

Database References

MDL Number
MFCD04039818

FAQ

The compound is subject to regulatory guidelines such as REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) in the European Union, which requires suppliers and manufacturers to register and evaluate the safety of chemicals. Additionally, it falls under the provisions of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes classification and labelling of the chemical based on its physical and health hazards. In the United States, the FDA and EPA may also have specific guidelines and requirements for the handling and use of this compound in pharmaceutical and agricultural applications.
There are several alternatives to this specific compound that can be used in synthesis, including related spiropyrans and xylopyranosides with similar structural features. Common alternatives include simpler spiropyrans that can be more readily synthesized and are widely available in the chemical market. Isomers and structural analogs may also serve as viable alternatives depending on the specific requirements of the synthesis.
The market and research trend for this compound suggests an increasing interest in its use as a photoreactive agent and in drug delivery systems. Research is focusing on its potential applications in photochemistry and materials science. Market trends indicate a growing demand in the pharmaceutical sector for compounds with unique optical and chemical properties. However, due to its complex structure, its market availability and application scope are currently limited.
Waste containing this compound should be handled with care to ensure environmental safety. Proper waste collection methods should be followed, and the waste should be disposed of according to local and international regulations. Incineration is a common method for waste disposal, as it reduces the volume of waste and destroys hazardous components. Additionally, professional waste disposal services can ensure the safe and compliant disposal of the waste. Environmental protection precautions should be taken to prevent soil and water contamination during the disposal process.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

sales@mail.biobiopha.com

Mobile

18788556290

Telephone

+86-871-65217109

Fax

+86-871-65215563